Video Statement by Dorian Des Lauriers, CEO of ProVerde Laboratories, Verifies Pure Quality of Medical Marijuana, Inc.’s CBD Hemp Oil Brands Including Real Scientific Hemp Oil™ (RSHO™), Others from HempMeds®
SAN DIEGO, July 1, 2015 (GLOBE NEWSWIRE) — Medical Marijuana, Inc. (OTC Pink:MJNA), an industrial hemp industry innovator and investor, released a video statement from one of the cannabis industry’s top product quality testing authorities: ProVerde Laboratories. Dorian A. Des Lauriers, Chief Executive Officer of ProVerde Laboratories, states that his company has tested MJNA brands including Real Scientific Hemp Oil™ (RSHO™) and others from HempMeds® for more than two years. In the video statement, Des Lauriers states these products are, “…perfectly clean for human consumption.”
A photo accompanying this release is available at http://www.globenewswire.com/newsroom/prs/?pkgid=34002
Des Lauriers explains further in the video statement, “ProVerde Laboratories is an industry leader in the testing space. We are an ISO/IEC 17025:2005 accredited laboratory with one of the broadest scopes of any lab in the industry for both hemp and marijuana testing.”
ProVerde uses highly sophisticated equipment – the same type of equipment as used by pharmaceutical companies around the world.
“We want to make sure that ProVerde Laboratories is providing outstanding testing with superior results,” Des Lauriers continues. “We are primarily focused on safety to make sure that your products are safe for you to consume.”
When asked specifically about the quality of CBD hemp oil sourced by Medical Marijuana, Inc. for testing at ProVerde Laboratories, Des Lauriers states, “We have never seen anything in there that shouldn’t be there – so no heavy metals, no solvents, nothing that is not supposed to be there.”
“Medical Marijuana, Inc. is an industrial hemp industry leader and the first publicly traded cannabis company,” states Stuart W. Titus, PhD, President and CEO of MJNA. “We take extreme pride in having invested years of time and millions of dollars to create the largest all-natural CBD hemp oil pipeline in the world. Our goal is and always will be product quality assurance, safety and accessibility for all.”
“Medical Marijuana, Inc.’s CBD hemp oil is tested at its origin in the EU, and is inspected upon arrival in the U.S.” Titus continues. “As you can imagine, Customs, FDA, and other government agencies would never allow in a hemp oil product if it were contaminated with toxic microbial life, mold or any other contaminants.”
Titus concludes, “After our CBD hemp oil passes all required parameters for open importation, our employees quarantine the oil as a double-failsafe then send it out for further testing to multiple cannabis and food safety labs for extra verification. We have used ISO/IEC 17025:2005 accredited food safety laboratory, ProVerde, for years and sincerely appreciate their attention to product quality and safety. Only if these independent tests verify the safety and accuracy of our suppliers’ tests and US-based inspectors’ tests will Medical Marijuana, Inc. consider beginning the manufacturing and packaging processes.”
Titus concludes, “Medical Marijuana, Inc. and management are extremely appreciative of the individuals, parents, organizations and shareholders who continue to trust and support the Company’s products and initiatives. Our brands, including Real Scientific Hemp Oil, are some of the world’s most trusted brands of CBD hemp oil in the world. We are thrilled to be making global headline news with acceptance of our flagship product RSHO™. In this rapidly growing industry, one thing our customer can count on is consistently receiving the highest quality product with every purchase.”
For more information on Medical Marijuana, Inc. visit the Company’s website.
HempMeds® offers mainstream marketing, sales, customer service, and logistics for the cannabis industry. HempMeds® is a corporate portfolio company of Medical Marijuana, Inc. (OTC Pink:MJNA) and the Company’s exclusive master distributor and contracted marketing company. In addition to handling sales and distribution, HempMeds® is the communication hub for the Medical Marijuana Inc. portfolio of companies.
About Medical Marijuana, Inc.
Our mission is to be the premier hemp industry innovators, leveraging our team of professionals to source, evaluate and purchase value-added companies and products, while allowing them to keep their integrity and entrepreneurial spirit. We strive to create awareness within our industry, develop environmentally-friendly, economically sustainable businesses, while increasing shareholder value. For more information, please visit the company’s website at: www.MedicalMarijuanaInc.com.
FOOD AND DRUG ADMINISTRATION (FDA) DISCLOSURE
These statements have not been evaluated by the FDA and are not intended to diagnose, treat or cure any disease.
This press release may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward-looking statements by definition involve risks, uncertainties and other factors, which may cause the actual results, performance or achievements of Medical Marijuana, Inc. to be materially different from the statements made herein.
Medical Marijuana, Inc. does not sell or distribute any products that are in violation of the United States Controlled Substances Act (US.CSA). The Company does grow, sell and distribute hemp-based products and are involved with the federally legal distribution of hemp-based products within certain international markets. Cannabidiol is a natural constituent of hemp oil.
The photo is also available via Newscom, www.newscom.com, and via AP PhotoExpress.
For further information, please contact:
Public Relations contact:
CMW Media P. 858-380-5478
Investor Relations: GH Investment Advisors 550 West “C” Street, Ste. 2040 San Diego, CA 92101 Nick Massalas Office: (858) 264-6500 Toll Free: (877) 964-6463